AZD4694: an Abeta plaque neuroimaging PET radioligand; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 24896605 |
CHEMBL ID | 2048308 |
SCHEMBL ID | 1923062 |
MeSH ID | M0550379 |
Synonym |
---|
CHEMBL2048308 |
azd4694 |
g5k506j69e , |
unii-g5k506j69e |
2-(2-fluoro-6-methylaminopyridin-3-yl)benzofuran-5-ol |
1054629-49-0 |
azd 4694 |
azd-4694 |
flutafuranol |
2-(2-fluoro-6-methylamino-pyridin-3-yl)-benzofuran-5-ol |
MYNQXTDIPMCJCR-UHFFFAOYSA-N |
SCHEMBL1923062 |
bdbm50485310 |
Q27278793 |
EX-A5369 |
HY-113938 |
2-[2-fluoro-6-(methylamino)pyridin-3-yl]-1-benzofuran-5-ol |
CS-0064225 |
AKOS040751827 |
Excerpt | Reference | Relevance |
---|---|---|
" Here, we report the preparation and pharmacokinetic profile of its carbon-11 (t1/2 = 20." | ( Synthesis, radiolabeling, and in vivo pharmacokinetic evaluation of the amyloid beta radioligand [11C]AZD4694 in nonhuman primates. Amini, N; Bergman, L; Cselenyi, Z; Farde, L; Gulyas, B; Halldin, C; Johnström, P; Lindström-Böö, E; Nakao, R; Sandell, J; Schou, M; Sumic, A; Svensson, S; Varnäs, K, 2014) | 0.62 |
"The advantageous pharmacokinetic profile and low nonspecific binding render [(11)C]AZD4694 a promising PET radioligand for imaging of amyloid beta in the human brain with PET." | ( Synthesis, radiolabeling, and in vivo pharmacokinetic evaluation of the amyloid beta radioligand [11C]AZD4694 in nonhuman primates. Amini, N; Bergman, L; Cselenyi, Z; Farde, L; Gulyas, B; Halldin, C; Johnström, P; Lindström-Böö, E; Nakao, R; Sandell, J; Schou, M; Sumic, A; Svensson, S; Varnäs, K, 2014) | 0.84 |
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Amyloid-beta precursor protein | Homo sapiens (human) | IC50 (µMol) | 0.0240 | 0.0005 | 3.8895 | 10.0000 | AID671384 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID671384 | Displacement of [3H]AZD2184 from human amyloid beta(1 to 40) | 2012 | Bioorganic & medicinal chemistry letters, Jul-01, Volume: 22, Issue:13 | Synthesis and evaluation of pyridylbenzofuran, pyridylbenzothiazole and pyridylbenzoxazole derivatives as ¹⁸F-PET imaging agents for β-amyloid plaques. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 8 (88.89) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (20.69) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (11.11%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 1 (11.11%) | 0.25% |
Other | 7 (77.78%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |